David Hallal

Mr. David L.
Hallal is an Independent Chairman at Kalaris Therapeutics, Inc., a Chairman at iTeos Therapeutics SA, an Executive Chairman at ElevateBio LLC, a Chairman at Scholar Rock, Inc. and a Chairman & Chief Executive Officer at Scholar Rock Holding Corp.
He is on the Board of Directors at LifeEDIT Therapeutics, Inc. and Pharmaceutical Research & Manufacturers of America.
Mr. Hallal was previously employed as an Executive Chairman by AlloVir, Inc., a Chairman by iTeos Therapeutics, Inc., an Independent Director by Seer, Inc. (California), a Chief Executive Officer & Director by Alexion Pharmaceuticals, Inc., a Vice President-Sales by (OSI) Eyetech, a Head-Sales by Biogen Idec, Inc., a Director-Southeast Oncology Sales by Amgen, Inc., and a Director-National Sales by Oldtech, Inc. He received his undergraduate degree from the University of New Hampshire.